CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 5686-5693

  Cabioglu, Neslihan ^a   Yazici, M Sertac ^a   Arun, Banu ^a   Broglio, Kristine R ^a   Hortobagyi, Gabriel N ^a   Price, Janet E ^a   Sahin, Aysegul ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PARAFFIN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EVALUATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 23844530896     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0014     Document Type: Article

References (35)

1. Ravdin PM, de Laurentis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994;86:1771-5.
2. Silverstein M, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767-72.
3. 1 breast carcinoma. Cancer 1997;79:1918-22.
4. Skobe M, Hawighorst T, Jackson OG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8
5. Yan C, Zhu ZG, Yu YY, et al. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their value as in predicting lymph node metastasis. World J Gastroenterol 2004;10:783-90.
6. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastases. Nature 2001;410:50-6.
7. Sloan EK, Anderson RL. Genes involved in breast cancer metastasis to bone. Cell Mol Life Sci 2001;59:1491-502.
8. Helbig G, Christopherson KW II, Bhat-Nakshatri P et al. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003;278:21631-8.
9. Lee BC, Lee TH, Avraham S, Avraham HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004;2:327-38.
10. Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004;23:157-67.
11. Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004;64:4302-8.
12. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 2003;105:186-9.
13. Ding Y, Shimada Y, Maeda M, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 2003;9:3406-12.
14. Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002;62:2937-41.
15. Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003;5:144-50.
16. Mittra I, Redkar AA, Badwe RA. Prognosis of breast cancer: evidence for interaction between c-erbB-2 Overexpression and number of involved axillary lymph nodes. J Surg Oncol 1995;60:106-1.
17. Anan K, Morisaki T, Katano M, et al. Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential. Eur J Surg Oncol 1998;24:28-33.
18. Sutterlin MW, Haller A, Gassel AM, Peters K, Caffier H, Oietl J. The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer. Anticancer Res 2000;20:5083-8.
19. 1 breast carcinomas? J Clin Pathol 2000;53:846-50.
20. 1 breast cancer: identification of patients at low risk of axillary lymph node metastases. Breast Cancer Res Treat 2002;76:11-7.
21. Schneider J, Pollan M, Tejerina A, Sanchez J, Lucas AR. Accumulation of uPA-PAI-I complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor positive early breast cancer. Br J Cancer 2003;88:96-101.
22. Cabioglu N, Summy J, Miller C, et al. CXCL-121 stromal cell-derived factor-1-alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res, in press.
23. Forster R, Schubel A, Breitfeld O, et al. CCR7 coordinates the primary immune response by establishing functional microenvironment in secondary lymphoid organs. Cell 1999;99:23-33.
24. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc Natl Acad Sci U S A 1998;95:258-63.
25. Gunn MD, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-60.
26. Wiley HE, Gonzalez EB, Maki W, Wu M, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001;93:1638-43.
27. Wang J, Xi L, Hunt JL, et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 2004;64:1861-6.
28. Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000;64:323-32.
29. Blades MC, Manzo A, Ingegnoli F, et al. Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice. J Immunol 2002;168:4308-17.
30. Uchida D, Begum NM, Almofti A, et al. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 2003;290:289-302.
31. Uchida D, Begum NM, Tomizuka Y, et al. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest 2004;84:1538-46.
32. Almofti A, Uchida D, Begum NM, et al. The clinico-pathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int J Oncol 2004;25:65-71.
33. Spano JP, Andre F, Morat L, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 2004;15:613-7.
34. Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004;6:459-69.
35. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-78.